• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Recontacting in clinical practice: the views and expectations of patients in the United Kingdom.临床实践中的再次联系:英国患者的观点与期望
Eur J Hum Genet. 2017 Oct;25(10):1106-1112. doi: 10.1038/ejhg.2017.122. Epub 2017 Aug 2.
2
Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom.临床实践中的再次联系:对英国医疗保健专业人员和临床科学家观点的调查。
Eur J Hum Genet. 2017 Feb;25(3):275-279. doi: 10.1038/ejhg.2016.188. Epub 2017 Jan 4.
3
Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom.临床实践中的再次接触:英国临床遗传学服务调查
Genet Med. 2016 Sep;18(9):876-81. doi: 10.1038/gim.2015.194. Epub 2016 Feb 18.
4
Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe.是否重新联系?欧洲临床遗传中心当前实践情况调查。
Eur J Hum Genet. 2018 Jul;26(7):946-954. doi: 10.1038/s41431-018-0131-5. Epub 2018 Apr 23.
5
Recontacting in light of new genetic diagnostic techniques for patients with intellectual disability: Feasibility and parental perspectives.鉴于针对智力残疾患者的新基因诊断技术进行再次联系:可行性及家长观点。
Eur J Med Genet. 2018 Apr;61(4):213-218. doi: 10.1016/j.ejmg.2017.11.017. Epub 2017 Nov 27.
6
Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics.临床遗传学服务中患者的再联系:欧洲人类遗传学会的建议。
Eur J Hum Genet. 2019 Feb;27(2):169-182. doi: 10.1038/s41431-018-0285-1. Epub 2018 Oct 11.
7
A 'joint venture' model of recontacting in clinical genomics: challenges for responsible implementation.临床基因组学中重新联系的“合资企业”模式:负责任实施面临的挑战
Eur J Med Genet. 2017 Jul;60(7):403-409. doi: 10.1016/j.ejmg.2017.05.001. Epub 2017 May 10.
8
Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines.专家们对再次联系患者和研究参与者的职责进行反思;为何专业人士应带头制定指导方针。
Eur J Med Genet. 2020 Feb;63(2):103642. doi: 10.1016/j.ejmg.2019.03.006. Epub 2019 Mar 20.
9
[Patient satisfaction regarding further telephone contact following attempted suicide].[自杀未遂后进一步电话联系的患者满意度]
Encephale. 2010 Jun;36 Suppl 2:D7-D13. doi: 10.1016/j.encep.2009.10.009. Epub 2009 Dec 1.
10
Recontacting in medical genetics: the implications of a broadening knowledge base.医学遗传学中的再联系:拓宽知识库的影响。
Hum Genet. 2022 May;141(5):1045-1051. doi: 10.1007/s00439-021-02353-5. Epub 2021 Aug 30.

引用本文的文献

1
Variant reclassification and recontact research: A scoping review.变异重新分类与重新联系研究:一项范围综述。
Genet Med Open. 2024 Jul 11;2:101867. doi: 10.1016/j.gimo.2024.101867. eCollection 2024.
2
Canadian College of Medical Geneticists: clinical practice advisory document - responsibility to recontact for reinterpretation of clinical genetic testing.加拿大医学遗传学家学院:临床实践咨询文件-重新联系进行临床遗传检测重新解释的责任。
J Med Genet. 2024 Nov 25;61(12):1123-1131. doi: 10.1136/jmg-2024-110330.
3
Parents' attitudes towards research involving genome sequencing of their healthy children: a qualitative study.父母对涉及健康子女基因组测序研究的态度:一项定性研究。
Eur J Hum Genet. 2024 Feb;32(2):171-175. doi: 10.1038/s41431-023-01476-9. Epub 2023 Oct 20.
4
Practices and Views of US Oncologists and Genetic Counselors Regarding Patient Recontact After Variant Reclassification: Results of a Nationwide Survey.美国肿瘤学家和遗传咨询师在变异再分类后对患者再次联系的实践和看法:一项全国性调查的结果。
JCO Precis Oncol. 2023 Jun;7:e2300079. doi: 10.1200/PO.23.00079.
5
Searching for a sense of closure: parental experiences of recontacting after a terminated pregnancy for congenital malformations.寻找终结感:父母在终止妊娠治疗先天畸形后重新联系的经历。
Eur J Hum Genet. 2024 Jun;32(6):673-680. doi: 10.1038/s41431-023-01375-z. Epub 2023 May 12.
6
Opinions and experiences of recontacting patients: a survey of Australasian genetic health professionals.再次联系患者的意见和经验:对澳大拉西亚遗传健康专业人员的一项调查。
J Community Genet. 2022 Apr;13(2):193-199. doi: 10.1007/s12687-021-00570-z. Epub 2022 Jan 11.
7
Patient and public preferences for being recontacted with updated genomic results: a mixed methods study.患者和公众对更新的基因组结果被再次联系的偏好:一项混合方法研究。
Hum Genet. 2021 Dec;140(12):1695-1708. doi: 10.1007/s00439-021-02366-0. Epub 2021 Sep 18.
8
Recontacting in medical genetics: the implications of a broadening knowledge base.医学遗传学中的再联系:拓宽知识库的影响。
Hum Genet. 2022 May;141(5):1045-1051. doi: 10.1007/s00439-021-02353-5. Epub 2021 Aug 30.
9
Of Screening, Stratification, and Scores.关于筛查、分层和评分
J Pers Med. 2021 Jul 28;11(8):736. doi: 10.3390/jpm11080736.
10
Recontacting registry participants with genetic updates through GenomeConnect, the ClinGen patient registry.通过 GenomeConnect(ClinGen 患者注册中心)向登记参与者提供遗传信息更新的联系方式。
Genet Med. 2021 Sep;23(9):1738-1745. doi: 10.1038/s41436-021-01197-8. Epub 2021 May 18.

本文引用的文献

1
A 'joint venture' model of recontacting in clinical genomics: challenges for responsible implementation.临床基因组学中重新联系的“合资企业”模式:负责任实施面临的挑战
Eur J Med Genet. 2017 Jul;60(7):403-409. doi: 10.1016/j.ejmg.2017.05.001. Epub 2017 May 10.
2
Recontacting in clinical genetics and genomic medicine? We need to talk about it.在临床遗传学和基因组医学中重新联系?我们需要谈谈这个问题。
Eur J Hum Genet. 2017 May;25(5):520-521. doi: 10.1038/ejhg.2017.8. Epub 2017 Feb 8.
3
Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom.临床实践中的再次联系:对英国医疗保健专业人员和临床科学家观点的调查。
Eur J Hum Genet. 2017 Feb;25(3):275-279. doi: 10.1038/ejhg.2016.188. Epub 2017 Jan 4.
4
Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom.临床实践中的再次接触:英国临床遗传学服务调查
Genet Med. 2016 Sep;18(9):876-81. doi: 10.1038/gim.2015.194. Epub 2016 Feb 18.
5
Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.该规则的例外情况:遗传性癌症基因中遗传变异致病性预测的案例研究。
Clin Genet. 2015 Dec;88(6):533-41. doi: 10.1111/cge.12560. Epub 2015 Feb 11.
6
Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature.鉴于新的基因技术,是否有再次联系的义务?文献系统综述。
Genet Med. 2015 Aug;17(8):668-78. doi: 10.1038/gim.2014.173. Epub 2014 Dec 11.
7
The coming explosion in genetic testing--is there a duty to recontact?基因检测即将迎来的爆发——是否有再次联系的义务?
N Engl J Med. 2011 Oct 13;365(15):1367-9. doi: 10.1056/NEJMp1107564.
8
What is clinical utility and why should we care?什么是临床效用,我们为什么要关心?
Clin Pharmacol Ther. 2010 Dec;88(6):729-33. doi: 10.1038/clpt.2010.229.
9
Evaluating the utility of personal genomic information.评估个人基因组信息的效用。
Genet Med. 2009 Aug;11(8):570-4. doi: 10.1097/GIM.0b013e3181a2743e.
10
What process attributes of clinical genetics services could maximise patient benefits?临床遗传学服务的哪些流程属性可以使患者受益最大化?
Eur J Hum Genet. 2008 Dec;16(12):1467-76. doi: 10.1038/ejhg.2008.121. Epub 2008 Jul 2.

临床实践中的再次联系:英国患者的观点与期望

Recontacting in clinical practice: the views and expectations of patients in the United Kingdom.

作者信息

Carrieri Daniele, Dheensa Sandi, Doheny Shane, Clarke Angus J, Turnpenny Peter D, Lucassen Anneke M, Kelly Susan E

机构信息

Egenis, University of Exeter, Exeter, UK.

Faculty of Medicine, University of Southampton, Southampton, UK.

出版信息

Eur J Hum Genet. 2017 Oct;25(10):1106-1112. doi: 10.1038/ejhg.2017.122. Epub 2017 Aug 2.

DOI:10.1038/ejhg.2017.122
PMID:28766552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5602023/
Abstract

This paper explores the views and expectations of patients concerning recontacting in clinical practice. It is based on 41 semi-structured interviews conducted in the United Kingdom. The sample comprised patients or parents of patients: without a diagnosis; recently offered a test for a condition or carrier risk; with a rare condition; with a variant of unknown significance - some of whom had been recontacted. Participants were recruited both via the National Health Service (NHS) and through online, condition-specific support groups. Most respondents viewed recontacting as desirable, however there were different opinions and expectations about what type of new information should trigger recontacting. An awareness of the potential psychological impact of receiving new information led some to suggest that recontacting should be planned, and tailored to the nature of the new information and the specific situation of patients and families. The lack of clarity about lines of responsibility for recontacting and perceptions of resource constraints in the NHS tended to mitigate respondents' favourable positions towards recontacting and their preferences. Some respondents argued that recontacting could have a preventative value and reduce the cost of healthcare. Others challenged the idea that resources should be used to implement formalised recontacting systems - via arguments that there are 'more pressing' public health priorities, and for the need for healthcare services to offer care to new patients.

摘要

本文探讨了患者在临床实践中对再次联系的看法和期望。它基于在英国进行的41次半结构化访谈。样本包括患者或患者的父母:未确诊;最近接受了某种疾病或携带者风险检测;患有罕见疾病;有意义未明的变异——其中一些人已经被再次联系过。参与者通过国民医疗服务体系(NHS)以及特定疾病的在线支持小组招募。大多数受访者认为再次联系是可取的,然而对于何种新信息应引发再次联系,存在不同的意见和期望。意识到接收新信息可能产生的心理影响,一些人建议再次联系应该有计划,并根据新信息的性质以及患者和家庭的具体情况进行调整。NHS中关于再次联系的责任界限不明确以及对资源限制的看法,往往会削弱受访者对再次联系的支持态度及其偏好。一些受访者认为再次联系可能具有预防价值并降低医疗成本。其他人则对将资源用于实施正式的再次联系系统的观点提出质疑——理由是存在“更紧迫”的公共卫生优先事项,以及医疗服务机构需要为新患者提供护理。